IGI, 10% Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Gammagard Liquid, KIOVIG, TAK-339

Filter by location:

Mobile, Alabama1 trial

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Infirmary Health - Diagnostic & Medical Clinic (DMC)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.